Inhalers are a key treatment for respiratory conditions, with approximately 60 million dispensed every year in the UK. However, evidence indicates that respiratory patients do not consistently receive care in line with best practice and inhalers are not used in an optimal way, leading to poor disease control and avoidable deaths. Medicines account for 25 per cent of emissions within the NHS and inhalers alone are responsible for 3 per cent of the NHS carbon footprint.

This session will follow a conversation with policy and practitioners on how primary care is working towards changing respiratory care to improve both patient care and reduce carbon emissions.

This session is part of the Sustainable Healthcare Zone, which is sponsored by Boehringer Ingelheim.